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Abstract
The neuropathogenesis of the human immunodeficiency virus (HIV) may manifest as various neurocognitive impairments
(NCI). HIV-positive individuals also have significantly shorter telomere length (TL) in peripheral blood mononuclear cells
(PBMCs) and CD8+ T cells compared to HIV-negative individuals. Additionally, reduced TL has been found to be associated
with chronic psychological stress. This study focused on the effects of HIV-infection and chronic stress associated with
childhood trauma on telomere length, and investigated whether leukocyte TL (LTL), in particular, represents a risk factor for
NCI. Eighty-three HIV-positive and 45 HIV-negative women were assessed for childhood trauma and were subjected to
detailed neurocognitive testing. Blood from each participant was used to extract Deoxyribonucleic acid (DNA). Relative LTL
were determined by performing real time quantitative PCR reactions as described by Cawthon et al. (2002). As expected,
relative LTL in the HIV-positive individuals was significantly shorter than that of HIV-negative individuals (F = 51.56,
p =,0.01). Notably, a significant positive correlation was evident between relative LTL and learning performance in the HIV-
positive group. In addition, a significant negative correlation was observed between relative LTL and verbal fluency, but this
association was only evident in HIV-positive individuals who had experienced trauma. Our results suggest that reduced LTL
is associated with worse learning performance in HIV-positive individuals, indicating that TL could act as a susceptibility
factor in increasing neurocognitive decline in HIV-infected individuals.
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Introduction
HIV/AIDS is a major health concern, particularly in South
Africa, where 10.6% of the South African population is estimated
to be infected with the human immunodeficiency virus (HIV)
(2011 statistics) [1]. Women bear the brunt of this disease, with
HIV prevalence among South African females highest in the 25–
29 year age group at 32.7% [2]. Moreover, an equally devastating
but unseen epidemic of abuse against women and children exists in
developing parts of the world, such as South Africa, where high
rates of gender-based violence, including childhood trauma,
intimate partner violence and rape, predominate [3]. Research
has shown that adults who experienced an increased number of
traumatic events during childhood, were more prone to various
health impairments, including cancer, chronic pulmonary disease,
coronary artery, alcoholism, depression, and drug abuse as well as
mental health problems, and cardiovascular risk factors such as
obesity, physical inactivity, and smoking [4].
HIV-1, the most common and pathogenic strain of the HI-virus,
invades the central nervous system (CNS) by crossing the brain
blood barrier (BBB) early in the course of infection, where it can
cause synaptodendritic injury through direct (e.g. viral proteins) or
indirect (e.g. neuro-inflammatory) mechanisms [3]. Although the
post-CART (combination antiretroviral therapy) era has seen a
decrease in the prevalence of classic HIV-associated brain
pathology (microglial nodules in HIV encephalitis), adverse effects
of the virus on the CNS continue to have a pervasive daily impact
on patients’ lives. CNS damage can be categorised according to
primary pathologies, damage caused due to the presence of the
virus, and secondary pathologies, consequences of immunosup-
pression [5]. This on-going injury may be driven by chronic
inflammation, abnormal immune activation in response to HIV
infection or low-level viral replication in the CNS [6] and result in
persistent HIV-associated neurocognitive disorders (HAND) [6].
HIV-related damage to the CNS may manifest as neurocogni-
tive disturbances, affecting abilities such as attention, memory,
executive function, language and perceptual skills [7]. Collectively
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termed HAND, these are a globally occurring phenomenon across
all viral clades [8]. HAND encompasses a spectrum of neurocog-
nitive disorders, ranging from less severe disorders, such as HIV-
associated asymptomatic neurocognitive impairment (ANI) and
HIV-1-associated mild neurocognitive disorder (MND) to the
more severe HIV-1-associated dementia (HAD) [9]. HAND has
been recorded at relatively high rates in South Africa - in a
recently study, 23.5% of HIV-infected South Africans were found
to suffer from HAND [10]. Although the most severe form of
HAND, HIV associated dementia, is less common in the CART
era, high rates of mild NCI persist through stages of infection
despite improved viral suppression and immune reconstitution
with CART. In view of partially irreversible CNS changes that
result from severe immunosuppression early in the course of
illness, timely and sustained CART can be protective against
adverse NCI [11].
Telomeres are nucleoprotein structures located at the ends of
chromosomes, protecting them from degradation [12]. Telomeres
are characterised by a variable number of tandemly repeated 59-
TTAGGG-39 segments [12]. Owing to the inability of DNA
polymerase to replicate the ends of linear chromosomes com-
pletely [13], telomeres shorten by approximately 20–200 base
pairs during each mitotic cell division [14]. The telomerase
enzyme, which adds telomeric DNA to the chromosomes, prevents
excessive telomere shortening [15]. TL thus serves as a marker of
cellular and biological aging [12] as well as a general index of
human organismic aging [16].
Additional factors that affect the rate of telomere attrition
include obesity [17], physical exercise [18], smoking [19], anti-
inflammatory medications [15] and oxidative stress [13,20]. The
maintenance of TL might be the missing link translating genetic
and environmental effects to aging and age related diseases.
Consequently, TL shortening has been associated with an
increased risk for age-related diseases and metabolic decline
[21,22,23]. Stress hormones, inflammation and oxidative stress
have been proposed as biochemical pathways that could mediate
the relationship between environmental factors and TL. Further-
more, depression and chronic stress have been associated with
high levels of 8- hydroxy-deoxyguanosine (8-OHdG) and a
reduction in anti-oxidant enzymes [24–28]. Telomeric DNA is
particularly sensitive to oxidative damage and in vitro activity of
telomerase is inhibited by oxidative stress [29,30]. It has been
hypothesised that the continuous immune activation caused by
HIV infection results in immune system exhaustion and subse-
quent shortening of telomeres [31]. Indeed, HIV-positive individ-
uals have been shown to have significantly shorter telomere length
in CD8+ T cells compared to HIV-negative individuals [32].
Recent evidence suggests that psychological and physiological
stress is significantly associated with lower telomerase activity, and
subsequently shorter TL [26]. Of relevance to the current study,
Epel et al., 2004 [33], Tyrka et al. (2010) [34], Kananen et al.,
(2010) [35], O’Donovan et al., (2011) [36] and Glass et al., (2010)
[37] observed associations between TL (as measured in adulthood)
and childhood trauma, thereby providing preliminary evidence
that early trauma accelerates cellular ageing. In addition, there is
now evidence that lifetime trauma may play a role in increased
cognitive impairments in HIV-positive patients [10], which may,
in turn, be associated with higher mortality rates. To investigate
the impact of childhood adversities on cognitive markers in adults
it has to be considered that lifetime trauma is a potential co-variate
that has to be considered. The mechanism by which chronic stress
impacts on neurocognitive impairment (associated with HIV) is
largely unknown. Identifying factors that may interact to increase
neurocognitive impairment could facilitate improvements in the
cognitive functioning of HIV infected individuals. Given the
potential effects of chronic stress on TL, particularly during
childhood, it is important to assess whether TL represents a risk
factor for increased neurocognitive impairment in individuals
exposed to early life trauma. We hypothesized that shorter TL
would be associated with an increased susceptibility to HIV
associated neurocognitive impairment in the context of early life
adversity. We also investigated whether childhood trauma would
have negative effects on relative LTL as described in previous
studies [33,34].
Materials and Methods
Ethics Statement
Written informed consent was obtained from all study
participants and ethical approval was granted by the human
health research ethics committee of Stellenbosch University, South
Africa (ethics reference number: N07/07/153). All clinical
investigations have been conducted according to the principles
expressed in the Declaration of Helsinki.
Sample
The study sample consisted of 128 women, 83 (64.84%) of
whom were HIV-positive (Table 1). Socio-demographic informa-
tion of all participants is provided in Table 2. Participants
underwent neurobehavioural testing for neurocognitive impair-
ment, using the International Neuropsychological Test Battery
developed by the HIV Neurobehavioral Research Centre, San
Diego (Table 3). A history of childhood trauma was assessed by a
trained research psychologist using a retrospective self-report
instrument, namely the Childhood Trauma Questionnaire - Short
Form (CTQ-SF) [38]. All the tests were assessed by a trained
research psychologist.
The CTQ-SF is a 28-item self-report inventory that provides
valid screening for histories of abuse and neglect. It assesses five
types of maltreatment including, emotional, physical, and sexual
abuse, and emotional and physical neglect. For the present study,
childhood trauma included emotional, physical, and sexual abuse
and emotional and physical neglect were assessed. Bernstein and
colleagues have categorised CTQ scores by type and severity but
essentially, they also do stratify according to the presence of
childhood trauma or it’s absence. A score of 25–31 is catergorised
as no abuse or minimal abuse. A score of 41–51 is regarded as low
to moderate abuse, scores from 56–68 is moderate to severe
trauma and 73–125 is categorised as severe to extreme abuse [38].
Due to the small samples size in this study, we did not stratify
accoding to the severity of the trauma, however we did use
Bernstein’s categories to disciminate between participants with no
childhood trauma and those who experienced childhood trauma.
Bernstein did not describe the categorisation for scores that were
between 31 and 41; we grouped participants with these scores into
the absence of childhood trauma category since they are at the
lower range of the spectrum. Participants with CTQ-SF scores of
41–125 were regarded as individuals that have experienced
childhood trauma and those with CTQ-SF scores of 25–40 were
regrded not to have experienced childhood trauma.
DNA Procedures
DNA was extracted from whole blood via standard procedures,
diluted to 25 ng/ml and amplified with QuantiFast TM SYBR
Green PCR kit (Qiagen, Hilden, Germany) as described by
Cawthon et al. (2002) [34], with minor modifications (different
PCR kits, HBG1 was used instead of 36B4, different annealing
temperatures). Primers specific for telomeric repeats (T) [39] and a
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stably expressed single copy reference gene (S), human b-globin
(HBG1, 59 GCTTCTGACACAACTGTGTTCACTAGC 39; and
HBG2, 59 CACCAACTTCATCCACGTTCACC 39) were used to
amplify telomeric repeats and human b -globin, respectively. For
the telomere assay each reaction included 5 ml QuantiFast 26
SYBR Green PCR Master Mix (Qiagen), 270 nM forward primer,
900 nM reverse primer, 25 ng genomic DNA and water to yield a
10 ml end volume. The composition of the human b-globin
reaction was identical to the telomere assay, except that 400 nM of
each forward and reverse primer was used for the b-globin assay.
The reactions for the telomeric repeats and the human b-globin
gene were amplified on separate 384-well plates. Each partici-
pant’s DNA sample was amplified in triplicate with both of the
aforementioned primer sets for quality control purposes. If the Ct
values of the triplicates of particular samples differed by more than
0.5, those samples were excluded. From the triplicate Ct values,
the means were calculated for each sample and used in subsequent
calculations. Amplification was performed on the ABI 7900HT
platform (Applied Biosystems, Foster City, CA, USA) using the
following thermal cycling profile for the telomere assay: 95uC for
5 min, followed by 40 cycles of 95uC for 10 sec and 58uC for
30 sec and a melt cycle of 95uC for 15 sec, 64uC for 15 sec and
95uC for 15 sec. The thermal cycling profile for the human b-
globin gene was as follows: 95uC for 5 min, followed by 40 cycles
of 95uC for 10 sec and 56uC for 30 sec and a melt cycle of 95uC
for 15 sec, 64uC for 15 sec and 95uC for 15 sec.
A calibrator sample was prepared by pooling equal amounts of
DNA from 40 HIV positive and 40 HIV negative participants for
the construction of a standard curve. The calibrator DNA sample
was serially diluted 1.68 fold per dilution, to produce a nine-point
standard curve, with DNA amounts ranging from 50 ng to
0.79 ng. After amplification of the serial dilutions, a linear plot of
the threshold cycle (Ct) versus the log value of the input amount of
DNA (standard curve) was constructed using ABI’s SDS v.2.3
software. The efficiency of a reaction was also determined from
the standard curve of that reaction. Threshold and baseline values
were used as determined by the SDS v.2.3 software. All Ct values
were corrected for the PCR efficiency and interplate calibration
was also performed (GenEx) [40].
A validated quantitative polymerase chain reaction (qPCR)
method [39] was used to determine relative telomere lengths in all
samples. First, the mean telomere repeat copy number (tel, T) was
normalised to a reference gene (single copy gene) (scg, S) copy
number to control for differences in DNA quantity. The T/S ratio
is proportional to the average telomere length. Thereafter, the
factor by which the T/S ratio differed between the experimental
sample and the calibrator sample was determined to provide an
indication of relative average telomere length:
T=S~2{DCt
Relative average telomere length~ 2{DDCt:
(whereDCt ~ Ct(tel){ Ct(scg))
A T/S.1 indicates that the average telomere length in the
sample is greater than that of the reference sample, and a T/S,1
indicates that the average telomere length in the experimental
sample is less than that in the reference sample. This reference
sample was a DNA sample created by pooling all the samples, at a
concentration of 29.76 ng. This measure of TL is only relative and
does not have a specific unit.
All participants underwent neurocognitive testing using the
International Neuropsychological Test Battery developed by the
HIV Neurobehavioral Research Centre (HNRC). The battery
comprises tests designed to measure cognition in a variety of ability
domains, namely: motor, verbal fluency, attention/working
memory, speed, learning, recall, and executive functioning (testing
done by a trained research psychologist). A list of tests is included
in Table 3.
Statistical Analyses
Spearman correlations were performed to determine whether
an association existed between relative LTL and any of the
neuropsychological test scores among the HIV-positive women
(low scores are indicative of neurocognitive decline) to determine if
LTL had an effect on HIV associated neurocognitive decline.
Neuropsychological scores were scaled into ability domains,
namely: motor, verbal fluency, attention/working memory, speed,
learning, recall, and executive functioning (Table 3). A global
score was also computed based on the aforementioned domains.
Owing to the effects of age and education on the neuropsycho-
logical performance, age and education were added as covariates
in the analyses on neuropsychological data.
Associations between possible confounding factors (age, educa-
tion, body mass index [BMI], trauma sub-type, traumatic life
Table 1. Group characteristics for HIV status, childhood trauma status, mean relative LTL and LTL standard deviation (SD) values
for all participants.
Effect Level of factor Level of factor N % LTL Mean (SD)a
Total 128 0.74 (0.32)
HIV_Status HIV-negative 45 35.16 0.98 (0.36)
HIV_Status HIV-positive 83 64.84 0.61 (0.2)
Childhood trauma No 62 48.44 0.78 (0.36)
Childhood trauma Yes 66 51.56 0.7 (0.28)
HIV_Status*childhood trauma HIV-negative No 27 21.09 1.02 (0.38)
HIV_Status*childhood trauma HIV-negative Yes 18 14.06 0.92 (0.35)
HIV_Status*childhood trauma HIV-positive No 35 27.34 0.59 (0.19)
HIV_Status*childhood trauma HIV-positive Yes 48 37.5 0.62 (0.2)
aAll LTL values are that of relative LTL and not absolute LTL. HIV (Human immunodeficiency virus), LTL (leukocyte telomere length), N (samples size), SD (standard
deviation).
doi:10.1371/journal.pone.0058351.t001
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experiences, post-traumatic stress disorder (PTSD) symptomatol-
ogy and alcohol abuse) and LTL were tested using Spearman
correlation tests. In addition, Spearman correlation tests were also
conducted to determine if there were any associations between
CD4 cell counts and LTL, viral load and LTL, ARV treatment
and LTL as well as ARV treatment and neuropsychological test
scores. Given that the majority of the participants (95.3%) were
black, association between LTL and ethnicity was not investigated.
Since 77% of the participants were infected with the clade C virus,
Table 2. Socio-demographic information of all participants.
Frequency
Handedness
Left 9 (7%)
Right 119 (92%)
Participant age
Mean 29.8
Mean of HIV-positive participants 31.6
Mean of HIV-negative participants 26.33
Minimum 18
Maximum 50
Ethnicity
Black 123 (95%)
Coloured 5 (4%)
Marital status
Single 91 (70%)
Married 26 (20%)
Living with a partner 3 (2%)
Separated 4 (3%)
Divorced 3 (2%)
Widowed 1 (1%)
Home language
English 4 (3%)
Afrikaans 16 (5%)
Xhosa 113 (88%)
Other 5 (4%)
Annual household income
Less than R10 000 101 (78%)
R10 000 - R20 000 21 (16%)
R20 000 - R40 000 1 (1%)
R40 000 - R60 000 2 (2%)
R60 000 - R100 000 1 (1%)
More than R100 000 2 (2%)
Highest level of education
Grade 7 1 (1%)
Grade 8 7 (5%)
Grade 9 12 (9%)
Grade 10 24 (19%)
Grade 11 49 (38%)
Grade 12 31 (24%)
Employment status
Employed 46 (36%)
Unemployed 82 (64%)
ARV treatment
Yes 13 (16%)
No 70 (84%)
Frequency
Handedness
Left 9 (7%)
Right 119 (92%)
Participant age
Table 2. Cont.
Frequency
Mean 29.8
Mean of HIV-positive participants 31.6
Mean of HIV-negative participants 26.33
Minimum 18
Maximum 50
Ethnicity
Black 123 (95%)
Coloured 5 (4%)
Marital status
Single 91 (70%)
Married 26 (20%)
Living with a partner 3 (2%)
Separated 4 (3%)
Divorced 3 (2%)
Widowed 1 (1%)
Home language
English 4 (3%)
Afrikaans 16 (5%)
Xhosa 113 (88%)
Other 5 (4%)
Annual household income
Less than R10 000 101 (78%)
R10 000–R20 000 21 (16%)
R20 000–R40 000 1 (1%)
R40 000–R60 000 2 (2%)
R60 000–R100 000 1 (1%)
More than R100 000 2 (2%)
Highest level of education
Grade 7 1 (1%)
Grade 8 7 (5%)
Grade 9 12 (9%)
Grade 10 24 (19%)
Grade 11 49 (38%)
Grade 12 31 (24%)
Employment status
Employed 46 (36%)
Unemployed 82 (64%)
ARV treatment
Yes 13 (16%)
No 70 (84%)
doi:10.1371/journal.pone.0058351.t002
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Table 3. Ability domains that were used to measure cognition in the International Neuropsychological Test Battery.
Neuropsychological domain Neuropsychological test
Speed of Information Processing
WAIS-III Digit Symbol
WAIS-III Symbol Search
Trail Making Test Part A
Attention/Working Memory
Paced Auditory Serial Addition Test
WMS-III Spatial Span
Abstraction/Executive Functioning
Wisconsin Card Sorting Test - computer version
Color Trails 1 and 2
Stroop Color Word Test
Halstead Category Test – computer version
Learning and Delayed Recall (2 domains)
Hopkins Verbal Learning Test, Revised
Brief Visuospatial Memory Test, Revised
Language
Controlled Oral Word Association Test (FAS)
Category Fluency (Animals, Action)
Motor
Grooved Pegboard Test (both hands)
Screening for effort
Hiscock Digit Memory Test
doi:10.1371/journal.pone.0058351.t003
Figure 1. Graph displaying the group characteristics for HIV status, childhood trauma status and mean relative LTL for the groups
and subgroups within the sample. No CT (childhood trauma) – participant didn’t experience childhood trauma, CT – participant experienced
childhood trauma. *p,0.01 indicates significant differences between the no childhood trauma HIV-negative and no childhood trauma HIV-positive
groups and no childhood trauma HIV-negative and childhood trauma HIV-positive groups. **p,0.01 indicates significant differences between
childhood trauma HIV-negative and childhood trauma HIV-positive groups and childhood trauma HIV-negative and no childhood trauma HIV-
positive.
doi:10.1371/journal.pone.0058351.g001
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viral clade was not corrected for as potential confounding factor in
the analyses.
A two way analysis of variance (ANOVA) was conducted to
determine if either HIV infection or childhood trauma, or their
interaction, had a significant effect on LTL. Childhood trauma
scores ranged from mild to severe, as determined by the self-
reported CTQ-SF scores [38]. In view of the relatively small
sample size, participants were stratified according to the presence
of childhood trauma (CTQ-SF scores of 41–125) or its absence
(CTQ-SF scores of 25–40) [41] and not by trauma severity. In
order to determine whether LTL or childhood trauma, or the
combination, had an effect on neurocognitive decline, an analysis
of covariance (ANCOVA), using LTL as a covariate, was
conducted.
A homogeneity of slopes ANOVA was performed to determine
whether LTL and neuropsychological scores were influenced by
the presence of childhood trauma. A p-value of #0.05 was
considered significant for all statistical tests.
Results
Of the 128 participants in this study, 64.84% were HIV-positive
and 51.56% reported a history of childhood trauma (according to
CTQ-SF cut-off scores of 41–125) (Table 1). The mean CTQ-SF
score for HIV-positive individuals were 47.27 (minimum=25,
maximum=89) and the mean CTQ-SF score for HIV-negative
individuals were 42.82 (minimum=25, maximum=81). The
majority of participants were black (95.3%), Xhosa speaking
(87.6%) and unemployed (63.6%), had a low household income
(less than R10 000) and had not attained Grade 12 level of
education (24% had attained Grade 12) (Table 2). We tested
several possible confounding factors (age, education, BMI, trauma
sub-type, traumatic life experiences, post-traumatic stress disorder
(PTSD) symptomatology and alcohol abuse) to establish if they
had an effect on relative LTL. As expected, relative LTL was
negatively correlated with age (r =20.26, p= 0.00) and all
subsequent analyses were corrected for age. None of the other
variables (education, body mass index [BMI], trauma sub-type,
traumatic life experiences, post-traumatic stress disorder (PTSD)
symptomatology, alcohol abuse, CD4 cell counts, viral load and
ARV treatment) had an effect on relative LTL. In addition, results
showed that ARV treatment did not have a significant effect on
neuropsychological tests scores.
Figure 1 shows the mean relative LTL for all the different
groups and subgroups within the sample, (statistically significant p
values are included). Univariate tests of significance revealed that
HIV infected individuals had significantly shorter relative LTL
[LTL Mean=0.61 (Figure 2) (Table 2)] compared to HIV
negative individuals [LTL Mean= 0.98 (Figure 2) (Table 2)]
(F = 51.56, p =,0.01). There was no significant independent
effect of childhood trauma on relative LTL (F= 0.51, p= 0.47)
(Figure 2). Additionally, there was no significant interaction effect
between HIV status and childhood trauma on relative LTL
(F= 1.77, p = 0.19).
In the HIV-positive group, a significant positive correlation was
observed between relative LTL and learning (r = 0.26, p = 0.02);
HIV-positive individuals scored significantly less in the FAS
(Controlled Oral Word Association Test) learning test (M=23.14,
Figure 2. Graph depicting relative LTL in the HIV-positive group (with and without childhood trauma) as well as the HIV-negative
group (with and without childhood trauma).
doi:10.1371/journal.pone.0058351.g002
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SD=4.20) than their HIV-negative counterparts (M=25.56,
SD=3.88). The correlation between relative LTL and learning
remained significant in regression analysis with age included.
Furthermore, a trend towards association was observed between
relative LTL and recall (r = 0.2, p= 0.06). Childhood trauma did
not have significant effects on either learning (F = 0.042, p= 0.84)
or memory recall (F = 0.34, p = 0.56) among HIV-positive women,
when relative LTL was included as a covariate (using the mean
relative LTL value (0.61) of the HIV-positive group).
To determine if the relationship between relative LTL and each
neuropsychological domain score was the same for the trauma/no
trauma groups, a homogeneity of slopes model was applied to test
whether the slopes of the two regression lines for childhood trauma
status were equal (within the HIV-positive group only). There was
a significant difference between the trauma/no trauma groups (no
age difference between the groups) in the correlation between
relative LTL and verbal fluency (F = 7.61, p = 0.007). There was
no correlation in the no trauma group (r = 0.00, p = 0.98), while in
the trauma group there was a significant negative correlation
(r =20.35, p = 0.01), whereby childhood trauma exposed women
with shorter relative LTL performed better on tasks of verbal
fluency.
Discussion
A number of studies have investigated the immunological effects
of increased telomere shortening in HIV-positive individuals. This
study is the first to investigate the effects of TL on neurocognition
in HIV-positive individuals, and in the context of childhood
trauma. Individuals infected with HIV suffer continuous immune
activation, which may lead to increased telomere shortening and
subsequent accelerated immune system ageing, exhaustion of
immune resources and the onset of immunodeficiency [31].
Owing to the sensitivity of telomeres to inflammation, chronic
inflammation in the CNS may lead to telomere shortening in
specific brain regions (white matter) as well as in PBMCs. TL
could arguably be added to a list of cofactors (e.g., drugs of abuse,
co-infections and age) [6] that might amplify neural injury.
Childhood abuse and other severe lifetime traumas can have
lasting effects on the brain. The hippocampus is involved in
learning and memory and is particularly sensitive to stress. It has
been shown that adults who were abused as children have smaller
hippocampal volumes [42]. In addition, a study by Gleissner and
Elgar (2001) [43] found that patients with damage to hippocampal
structures performed worse in verbal fluency tasks, especially tasks
of semantic fluency [43].
We hypothesized that shorter relative LTL would contribute to
increased cognitive impairments (associated with HIV) in the
context of childhood trauma. We also investigated whether
childhood trauma would have negative effects on relative LTL
as described in previous studies [33,34]. We found that relative
LTL negatively influenced the learning process in HIV-positive
individuals, indicating that relative LTL could possibly act as a
susceptibility factor in increased neurocognitive decline in HIV
infected individuals. This could be explained by the fact that
excessive telomere shortening could potentially occur in white
matter [44] (secondary to HIV infection) which, in turn, could lead
to impairments in learning and affect memory recall ability [6].
Our results also indicated that the HIV-positive women had
significantly shorter relative LTL compared to HIV-negative
women; this is in line with findings from other studies that have
investigated TL in PBMCs [45] and in the CD8+ T cell subset
[32].
We did not find a significant association between relative LTL
and childhood trauma. Self-reported childhood trauma ranged
from mild to severe based on CTQ-SF scores [41]. Owing to small
group sizes, we did not stratify childhood trauma on severity which
might explain the lack of association between childhood trauma
and relative LTL. In addition, telomere attrition is a relatively slow
process and can best be investigated in a longitudinal study,
however, this was a cross sectional study and the mean age of the
participants were only 29.8 years, attributing to the lack of
association between relative LTL and childhood trauma. We did
find within the HIV-positive group that childhood trauma
influenced the effect of relative LTL on verbal fluency (as
indicated by the homogeneity of slopes model), suggesting that
individuals who have experienced childhood trauma and have
shorter relative LTL perform better in verbal fluency tasks. This
finding is contrary to expectation; however, Harris et al. (2006)
obtained similar results in a study that investigated TL, physical
health, cognitive ageing, and mortality in non-demented elderly
individuals [46]. They found a small significant negative associ-
ation between TL and verbal fluency (based on the executive
functioning test results) after they corrected for mental ability at
age 11. The explanation for their finding remains to be elucidated
[46].
Telomere length can be affected by a number of confounding
factors, including those previously mentioned (age, education,
body mass index [BMI], trauma sub-type, traumatic life experi-
ences, post-traumatic stress disorder (PTSD) symptomatology and
alcohol abuse). One of the limitations of the study is that there
were variables that were not corrected for such as physical exercise
[18], anti-inflammatory medications [15] and (for the small group
of women on antiretroviral [ARV] treatment) the duration of
ARV treatment, as this information was not available. The
association between shorter telomeres and severity of NCI may
reflect the fact that either or both these factors could be associated
with time since diagnosis or with medication. Future studies
controlling for these factors will be needed to confirm these
findings. Also, information on HIV-related variables such as nadir
CD4 counts, history of prior immunosuppression and time since
infection was not available and could therefore not be controlled
for in the analyses. The small sample size also placed a limitation
on the study and prohibited sub grouping for childhood trauma
severity. An additional limitation is that relative LTL was
investigated in PBMCs as a whole. Studies have shown that
telomere dynamics differ between subsets of PBMCs especially in
different disease stages [47–49]. A comparative study comparing
relative LTL in different brain regions (involved in the learning
process) in HIV-positive and negative individuals would shed light
on telomere dynamics in the brain and might explain the effect
that relative LTL could have on neurocognitive decline associated
with HIV infection. Further investigation of telomere length as a
potential early biomarker of NCI in HIV, particularly in the
setting of early life adversity, is important, both in terms of
prevention and intervention efforts in neuroAIDs research. Future
studies could also investigate neuroimaging endophenotypes of
TL. Comparison of TL with regional brain deficits in HIV-positive
individuals with NCI, those without NCI, and in HIV-negative
individuals would also broaden our understanding of the specific
effects of TL on HIV associated NCI and brain deficits. Moreover,
larger samples would allow for stratification by childhood trauma
severity and could enable detection of TL associations.
In summary, while a number of studies have investigated the
immunological effects of increased telomere shortening in HIV-
positive individuals, this is the first to describe an association
between shorter telomeres and HIV associated NCI in the context
Telomere Length in HIV and Childhood Trauma
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of early life adversity. Our results indicated that LTL differed
between HIV-positive and negative individuals and that there is a
significant positive correlation between LTL and learning. LTL
could therefore be a susceptibility factor in the development of
HAND.
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